Clinical Trial: Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754331) titled 'Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin' on July 13.

Brief Summary: The purpose of this study is to investigate the effect of HD on single oral dose PK, safety, and tolerability of balcinrenone/dapagliflozin to male and female participants with kidney failure on intermittent HD.

Study Start Date: Aug. 05

Study Type: INTERVENTIONAL

Condition: Kidney Failure

Intervention: DRUG: Balcinrenone/dapagliflozin

40 mg/10 mg balcinrenone/dapagliflozin (capsule)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Published by HT Digital Content Servic...